Thursday, 15 May 2008

Moviprep: Salix Pharma sue Novel Lab

Salix Pharma announced that it has filed a lawsuit in the United States District Court for the District of New Jersey against Novel Lab, for infringement of Norgine's patent US7169381, which covers Moviprep (PEG 3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate and ascorbic acid for oral solution) formulation. Norgine licensed Moviprep to Salix for commercialization in the United States. The lawsuit is in response to ANDA filed by Novel with the USFDA regarding Novel's intent to market a generic version of Mviprep in the United States prior to the expiration of US 7169381 (September 1, 2024).

Posted by ADKS at 1:32 pm

web page statistics
Disclaimer: "IP Pharma Doc" blog is published for information purpose only. "IP Pharma Doc" blog contains no legal advice. I assume no legal responsibility for the views/information expressed here. “IP Pharma Doc” blog is my personal website and not edited by my employer, accordingly, no part of my blog should be attributed to my employer. All information on the present blog should be double checked for its accuracy and applicability. © Dr. Sarwal (2007)
 
eXTReMe Tracker